全球透明質酸市場：2007年

Abstract

MRG is the largest medical device market research company in the world, providing unrivalled advantages to our clients. Global Markets for Hyaluronic Acid 2007 provides the accuracy you demand and the deep domain expertise you expect. We ensure quality control, consistency, and timeliness. Benefit from our substantial resources and industry sources. Receive the most detailed and specifi c information and analysis that is simply not available elsewhere.

ANSWERING YOUR QUESTIONS

• Includes analysis of the US, various European, and various Asia Pacifi c markets.
• The global market for HA treatment comprises market analysis of HA viscosupplementation products for
• orthopedic use, ophthalmic viscoelastics, and HA dermal fi llers for facial aesthetics.
• Sales of Hyaluronic Acid (HA) will be driven by an aging population and the subsequent demand for HA
• products that either treat age-related diseases or impairments.

COMPETITOR COVERAGE

MRG' s extensive competitor coverage allows you to keep your fi nger on the pulse of the market and your eye on the competition.

• Alcon
• AMO
• Anika Therapeutics
• Bausch & Lomb
• Bioniche Life Sciences
• Bio-Technology General
• Chemedica
• Chugai Pharmaceutical
• Corneal
• Fidia Pharmaceuticals
• Genzyme Biosurgery
• Inamed
• Laboratoires Genevrier
• Maruho
• Q-Med
• Rottapharm
• Sanofi -Aventis
• Santen
• Seikagaku Corporation
• Taisho Pharmaceutical
• Tedec-Meiji
• Vitrolife (Biomet)
• ...AND MORE!!!

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 GLOBAL HYALURONIC ACID MARKET

• 1.1 HA Overview
  • 1.1.1 HA Applications
  • 1.1.1.1 Orthopedic Uses
  • 1.1.1.2 Ophthalmic Uses
  • 1.1.1.3 Facial Aesthetic Uses
  • 1.1.1.4 Other Applications
• 1.2 Market Overview
• 1.3 Market Analysis
  • 1.3.1 Countries Covered
  • 1.3.2 Procedure Overview
  • 1.3.3 Market Forecast
    • 1.3.3.1 HA Viscosupplementation Market
    • 1.3.3.2 Ophthalmic Viscoelastics
    • 1.3.3.3 HA Dermal Fillers
  • 1.3.4 Market Drivers and Limiters
    • 1.3.4.1 Market Drivers
    • 1.3.4.2 Market Limiters
• 1.4 Competitive Analysis

2.0 HYALURONIC ACID VISCOSUPPLEMENTATION

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Procedure Overview
    • 2.2.1.1 US Procedure Overview
    • 2.2.1.2 European Procedure Overview
    • 2.2.1.3 Japanese Procedure Overview
• 2.3 Market Forecast
  • 2.3.1 US Market Forecast
    • 2.3.1.1 3-injection Hyaluronic Acid Market
    • 2.3.1.2 5-injection HA Viscosupplementation Market
  • 2.3.2 European Market Forecast
    • 2.3.2.1 Austrian Market Forecast
    • 2.3.2.2 French Market Forecast
    • 2.3.2.3 German Market Forecast
    • 2.3.2.4 Italian Market Forecast
    • 2.3.2.5 Spanish Market Forecast
    • 2.3.2.6 UK Market Forecast
  • 2.3.3 Japanese Market Forecast
  • 2.3.4 Market Drivers and Limiters
    • 2.3.4.1 Market Drivers
    • 2.3.4.2 Market Limiters
  • 2.3.5 Competitive Analysis

3.0 OPHTHALMIC VISCOELASTICS

• 3.1 Market Overview
  • 3.1.1 Procedure Overview
  • 3.1.2 US Market Forecast
  • 3.1.3 European Market Forecast
  • 3.1.4 Japanese Market Forecast
  • 3.1.5 Market Drivers and Limiters
    • 3.1.5.1 Market Drivers
    • 3.1.5.2 Market Limiters
• 3.2 Competitive Analysis

4.0 HYALURONIC ACID DERMAL FILLERS

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Procedure Overview
    • 4.2.1.1 US Procedure Overview
    • 4.2.1.2 European Procedure Overview
    • 4.2.1.3 Asia Pacific Procedure Overview
• 4.3 Market Forecast
  • 4.3.1 US Market Forecast
    • 4.3.1.1 Synthetic HA Dermal Fillers
    • 4.3.1.2 Animal Derived HA Dermal Fillers
  • 4.3.2 European Market Forecast
    • 4.3.2.1 French Market Forecast
    • 4.3.2.2 German Market Forecast
    • 4.3.2.3 Italian Market Forecast
    • 4.3.2.4 UK Market Forecast
    • 4.3.2.5 Standard HA Dermal Filler
    • 4.3.2.6 HA Rejuvenation
  • 4.3.3 Asia Pacific Market Forecast
    • 4.3.3.1 Chinese Market Forecast
    • 4.3.3.2 Japanese Market Forecast
    • 4.3.3.3 South Korean Market Forecast
    • 4.3.3.4 Thai Market Forecast
  • 4.3.4 Market Drivers and Limiters
    • 4.3.4.1 Market Drivers
    • 4.3.4.2 Market Limiters
• 4.4 Competitive Analysis
  • 4.4.2 Established Competitors
  • 4.4.3 Emerging Competitors

List of Exhibits

Executive Summary

• Exhibit ES-1: HA Treatment Market, Global (US$), 2004- 2010
• Exhibit ES-2: HA Treatment Market, Country Coverage, Global, 2005
• Exhibit ES-3: HA Treatment Procedures, Global, 2004- 2010
• Exhibit ES-4: HA Treatment Market, by Segment, as a % of Total, Global, 2005 and 2010
• Exhibit ES-5: Leading Competitors in the HA Market, Global, 2005 Methodology
• Exhibit M-1: Currency Exchange Rates, 2006

Chapter 1: Global Markets for Hyaluronic Acid

• Exhibit 1-1: HA Market, Global (US$), 2004- 2010 (Graphical Format)
• Exhibit 1-2: HA Market, by Segment, Global (US$), 2004- 2010 (Tabular Format)
• Exhibit 1-3: HA Market, by Region, Global (US$), 2004- 2010 (Tabular Format)
• Exhibit 1-4: Countries Covered, Global Hyaluronic Acid Market, 2007
• Exhibit 1-5: HA Treatment Procedures, Global, by Region, 2004- 2010 (Graphical Format)
• Exhibit 1-6: HA Treatment Procedures, Global, by Region, 2004- 2010 (Tabular Format)
• Exhibit 1-7: HA Treatment Procedures, Europe, by Country, 2004- 2010
• Exhibit 1-8: HA Treatment Procedure Volumes, Asia Pacific, by Country, 2004- 2010
• Exhibit 1-9: Drivers of the HA Market, Global, 2005
• Exhibit 1-10: Limiters of the HA Market, Global, 2005
• Exhibit 1-11: Leading Competitors in the HA Market, Global, 2005
• Exhibit 1-12: Leading Competitors in the HA-Based Treatment Market, by Segment, Global, 2005

Chapter 2: Hyaluronic Acid Viscosupplementation

• Exhibit 2-1: HA Viscosupplementation Market, by Region, as a % of Total, Global, 2005
• Exhibit 2-2: HA Viscosupplementation Market, by Region, (US$M), Global, 2005
• Exhibit 2-3: HA Viscosupplementation Treatment Volumes, by Region, Global, 2005 (Graphical Format)
• Exhibit 2-4: HA Viscosupplementation Treatment Volumes, by Region, Global, 2005
• Exhibit 2-5: HA Procedure Segmentation, by Number of Injections, US, 2005
• Exhibit 2-6: HA Injections, by Type, US, 2004- 2010
• Exhibit 2-7: HA Treatments, by Type, US, 2004- 2010
• Exhibit 2-8: HA Treatment Volumes, US, 2004- 2010
• Exhibit 2-9: HA Injections and Treatments, Europe, 2005
• Exhibit 2-10: HA Viscosupplementation Treatments, Europe, 2004- 2010
• Exhibit 2-11: HA Injections, by Country, Europe, 2004- 2010
• Exhibit 2-12: HA Treatments and Injections, Japan, 2004- 2010
• Exhibit 2-13: HA Viscosupplementation Treatment Market US, (US$), 2004- 2010 (Graphical Format)
• Exhibit 2-14: HA Viscosupplementation Treatment Market, US (US$), 2004- 2010 (Tabular Format)
• Exhibit 2-15: 3-Injection HA Injection Volumes, US, 2004- 2010
• Exhibit 2-16: 3-Injection HA Viscosupplementation Injection, by Indication, US, 2004- 2010
• Exhibit 2-17: 3-Injection HA Viscosupplementation Injection Market, US (US$), 2004- 2010
• Exhibit 2-18: 3-Injection HA Viscosupplementation Treatment, by Indication, US, 2004- 2010
• Exhibit 2-19: 3-Injection HA Viscosupplementation Treatment Market, US (US$), 2004- 2010
• Exhibit 2-20: 5-Injection HA Viscosupplementation Treatment Volumes, US, 2004- 2010
• Exhibit 2-21: 5-injection HA Viscosupplementation Injection Market, US (US$), 2004- 2010
• Exhibit 2-22: 5-injection HA Viscosupplementation Injection Market, by Indication, US (US$), 2004- 2010
• Exhibit 2-23: 5-injection HA Viscosupplementation Treatment Market, US (US$), 2004- 2010
• Exhibit 2-24: 5-injection HA Viscosupplementation Treatment Market, by Indication, US, 2004- 2010
• Exhibit 2-25: HA Viscosupplementation Treatment Market, Europe, (US$), 2004- 2010 (Graphical Format)
• Exhibit 2-26: HA Viscosupplementation Injection Market, Europe (US$), 2004- 2010
• Exhibit 2-27: HA Viscosupplementation Injection Market, Europe (€ ),2004- 2010
• Exhibit 2-28: HA Viscosupplementation Treatment Market, Europe (US$), 2004- 2010 (Tabular Format)
• Exhibit 2-29: HA Viscosupplementation Treatment Market, Europe (€ ), 2004- 2010
• Exhibit 2-30: HA Viscosupplementation Injections, Breakdown by Treatment, 2005
• Exhibit 2-31: HA Viscosupplementation Treatments, Austria, 2004- 2010
• Exhibit 2-32: HA Viscosupplementation Injection Market, Austria (US$), 2004- 2010
• Exhibit 2-33: HA Viscosupplementation Injection Market, Austria (€ ), 2004- 2010
• Exhibit 2-34: HA Viscosupplementation Treatment Market, Austria (US$), 2004- 2010
• Exhibit 2-35: HA Viscosupplementation Treatment Market, Austria (€ ), 2004- 2010
• Exhibit 2-36: HA Viscosupplementation Treatments, France, 2004- 2010
• Exhibit 2-37: HA Viscosupplementation Injection Market, France (US$), 2004- 2010
• Exhibit 2-38: HA Viscosupplementation Injection Market, France (€ ), 2004- 2010
• Exhibit 2-39: HA Viscosupplementation Treatment Market, France (US$), 2004- 2010
• Exhibit 2-40: HA Viscosupplementation Treatment Market, France (€ ), 2004- 2010
• Exhibit 2-41: HA Viscosupplementation Treatments, Germany, 2004- 2010
• Exhibit 2-42: HA Viscosupplementation Injection Market, Germany (US$), 2004- 2010
• Exhibit 2-43: HA Viscosupplementation Injection Market, Germany (€ ), 2004- 2010
• Exhibit 2-44: HA Viscosupplementation Treatment Market, Germany (US$), 2004- 2010
• Exhibit 2-45: HA Viscosupplementation Treatment Market, Germany (€ ), 2004- 2010
• Exhibit 2-46: HA Viscosupplementation Treatments, Italy, 2004- 2010
• Exhibit 2-47: HA Viscosupplementation Injection Market, Italy (US$), 2004- 2010
• Exhibit 2-48: HA Viscosupplementation Injection Market, Italy (€ ), 2004- 2010
• Exhibit 2-49: HA Viscosupplementation Treatment Market, Italy (US$), 2004- 2010
• Exhibit 2-50: HA Viscosupplementation Treatment Market, Italy (€ ), 2004- 2010
• Exhibit 2-51: HA Viscosupplementation Treatments, Spain, 2004- 2010
• Exhibit 2-52: HA Viscosupplementation Injection Market, Spain (US$), 2004- 2010
• Exhibit 2-53: HA Viscosupplementation Injection Market, Spain (€ ), 2004- 2010
• Exhibit 2-54: HA Viscosupplementation Treatment Market, Spain (US$), 2004- 2010
• Exhibit 2-55: HA Viscosupplementation Treatment Market, Spain (€ ), 2004- 2010
• Exhibit 2-56: HA Viscosupplementation Treatments, UK, 2004- 2010
• Exhibit 2-57: HA Viscosupplementation Injection Market, UK (US$), 2004- 2010
• Exhibit 2-58: HA Viscosupplementation Injection Market, UK (€ ), 2004- 2010
• Exhibit 2-59: HA Viscosupplementation Injection Market, UK (£), 2004- 2010
• Exhibit 2-60: HA Viscosupplementation Treatment Market, UK (US$), 2004- 2010
• Exhibit 2-61: HA Viscosupplementation Treatment Market, UK (€ ), 2004- 2010
• Exhibit 2-62: HA Viscosupplementation Treatment Market, UK (£), 2004- 2010
• Exhibit 2-63: HA Viscosupplementation Market, Japan (US$), 2004- 2010
• Exhibit 2-64: HA Viscosupplementation Injection Market, Japan (US$), 2004- 2010 (Tabular Format)
• Exhibit 2-65: HA Viscosupplementation Injection Market, Japan (¥), 2004- 2010
• Exhibit 2-66: Drivers and Limiters of the HA Viscosupplementation Market, Global, 2005
• Exhibit 2-67: Over-65 cohort as a % of Total Population, Europe, Japan and US, 2005-2050
• Exhibit 2-68: Leading Competitors in the HA Viscosupplementation Market, Global, 2005
• Exhibit 2-69: Leading Competitors in the HA Viscosupplementation Market, by Region, Global, 2005

Chapter 3: Ophthalmic Viscoelastics

• Exhibit 3-1: Ophthalmic Viscoelastics Market, by Region, as a % of Total, Global, 2004- 2010 (Graphical Format)
• Exhibit 3-2: Ophthalmic Viscoelastics Market, by Region, as a % of Total, Global, 2004- 2010
• Exhibit 3-3: Ophthalmic Viscoelastics Market, US, (US$), 2004- 2010
• Exhibit 3-4: Viscoelastics Market, Segmented by Country, Europe (US$), 2004- 2010 (Tabular Format)
• Exhibit 3-5: Viscoelastics Market, Segmented by Country, Europe (€ ), 2004- 2010
• Exhibit 3-6: Viscoelastics Market, Segmented by Country, UK (£), 2004- 2010
• Exhibit 3-7: Ophthalmic Viscoelastic Market, Japan (US$M), 2004- 2010
• Exhibit 3-8: Ophthalmic Viscoelastics Market, Japan (¥), 2004- 2010
• Exhibit 3-9: Drivers and Limiters of the Ophthalmic Viscoelastic Market, Global, 2005
• Exhibit 3-10: Leading Competitors in the Ophthalmic Viscoelastic Market, Global, 2005
• Exhibit 3-11: Leading Competitors in the Ophthalmic Viscoelastic Market, by Region, Global, 2005

Chapter 4: Hyaluronic Acid Dermal Fillers

• Exhibit 4-1: HA Dermal Filler Market, by Region, as a % of Total, Global, 2004- 2010
• Exhibit 4-2: HA Dermal Filler Market, by Region, Global, (US$), 2004- 2010
• Exhibit 4-3: HA Dermal Filler Procedure Volumes, Global, Segmented by Region, 2004- 2010 (Graphical Format)
• Exhibit 4-4: HA Dermal Filler Procedure Volumes, Global, Segmented by Region, 2004- 2010 (Tabular Format)
• Exhibit 4-5: HA Dermal Filler Procedures, by Segment, US, 2004- 2010 (Graphical Format)
• Exhibit 4-6: HA Dermal Filler Procedures, by Segment, US, 2004- 2010 (Tabular Format)
• Exhibit 4-7: HA Dermal Filler Procedures, by Country, Europe, 2004- 2010
• Exhibit 4-8: Standard HA Dermal Filler Procedures, by Country, Europe, 2004- 2010
• Exhibit 4-9: HA Dermal Filler Rejuvenation Procedures, by Country, Europe, 2004- 2010
• Exhibit 4-10: HA Dermal Filler Procedures, Asia Pacific, 2004- 2010
• Exhibit 4-11: HA Dermal Filler Market, US, (US$), 2004- 2010 (Graphical Format)
• Exhibit 4-12: HA Market, US, 2004- 2010 (Tabular Format)
• Exhibit 4-13: HA Market, by Segment, US, 2004- 2010
• Exhibit 4-14: Synthetic HA Dermal Filler Market, US, (US$), 2004- 2010
• Exhibit 4-15: Animal Derived HA Dermal Filler Market, US, (US$), 2004- 2010 (Tabular Format)
• Exhibit 4-16: HA Dermal Filler Market, Europe, (US$), 2004- 2010
• Exhibit 4-17: HA Dermal Filler Market, Europe, (€ ), 2004- 2010
• Exhibit 4-18: HA Dermal Filler Market, by Country, Europe (US$), 2004- 2010
• Exhibit 4-19: HA Dermal Filler Market, by Country, Europe (€ ), 2004- 2010
• Exhibit 4-20: HA Dermal Filler Market Growth, by Country, Europe, 2005- 2010
• Exhibit 4-21: Standard HA Dermal Filler Market, by Country, Europe (US$),2004- 2010
• Exhibit 4-22: Standard HA Dermal Filler Market, by Country, Europe (€ ), 2004- 2010
• Exhibit 4-23: Standard HA Dermal Filler Market Growth, by Country, Europe, 2005- 2010
• Exhibit 4-24: HA Dermal Filler Rejuvenation Market, by Country, Europe (US$), 2004- 2010
• Exhibit 4-25: HA Dermal Filler Rejuvenation Market, by Country, Europe (€ ), 2004- 2010
• Exhibit 4-26: HA Dermal Filler Rejuvenation Market Growth, by Country, Europe, 2005- 2010
• Exhibit 4-27: Total HA Dermal Filler Units, by Country, Europe, 2004- 2010
• Exhibit 4-28: Total HA Dermal Filler Unit Growth, by Country, Europe, 2005- 2010
• Exhibit 4-29: Total HA Dermal Filler ASP, by Country, Europe (US$), 2004- 2010
• Exhibit 4-30: Total HA Dermal Filler ASP Growth, by Country, Europe, 2005- 2010
• Exhibit 4-31: Total HA Dermal Filler Market Value, by Country, Europe (US$), 2004- 2010
• Exhibit 4-32: Total HA Dermal Filler Market Value Growth, by Country, Europe, 2005- 2010
• Exhibit 4-33: Standard HA Dermal Filler Units, by Country, Europe, 2004- 2010
• Exhibit 4-34: Standard HA Dermal Filler ASP, by Country, Europe (US$), 2004- 2010
• Exhibit 4-35: HA Dermal Filler Market, by Country, Asia Pacific (US$), 2004- 2010
• Exhibit 4-36: HA Dermal Filler Market, by Country, Asia Pacific (Local Currencies), 2004- 2010
• Exhibit 4-37: HA Market Growth, by Country, Asia Pacific, 2005- 2010
• Exhibit 4-38: HA Units, by Country, Asia Pacific, 2004- 2010
• Exhibit 4-39: HA Unit Growth, by Country, Asia Pacific, 2004- 2010
• Exhibit 4-40: HA ASP, by Country, Asia Pacific (US$), 2004- 2010
• Exhibit 4-41: HA ASP Growth, by Country, Asia Pacific, 2004- 2010
• Exhibit 4-42: HA Market, by Country, Asia Pacific, 2004- 2010
• Exhibit 4-43: HA Market Growth, by Country, Asia Pacific, 2004- 2010
• Exhibit 4-44: Drivers and Limiters of the HA Dermal Filler Market, Global, 2005
• Exhibit 4-45: Leading Competitors in the HA Dermal Filler Market, Global, 2005
• Exhibit 4-46: Leading Competitors in the HA Dermal Filler Market, by Region, Global, 2005